Eman M. Elsabbagh: Pediatric Nonmalignant HCT Enters the Era of Precision Conditioning and Gene Therapy
Eman M. Elsabbagh, Physician Scientist, Director at CITADEL Lab, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Slack Journals, adding:
“Pediatric nonmalignant HCT is moving into a precision era. The goal is no longer simply to achieve engraftment, but to maximize cure while minimizing toxicity and long term burden.
In our review, ‘Pediatric Nonmalignant Hematopoietic Cell Transplantation in the Era of Precision Conditioning and Gene Therapy,’ we discuss how the field is evolving through:
- disease adapted and reduced toxicity conditioning
- pharmacokinetic guided approaches
- broader donor options
- earlier referral and improved patient selection
- the expanding role of gene therapy as an alternative curative strategy
The central question is increasingly not just whether to transplant, but which curative platform is best, for which child, and at what time.
Published in the September 2026 special issue of Pediatric Annals.”
Title: Pediatric Nonmalignant Hematopoietic Cell Transplantation in the Era of Precision Conditioning and Gene Therapy
Authors: Eman M. Elsabbagh, Ahmed A. Shawky, Christopher C. Dvorak
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 8, 2026, 10:50Dena Winchester: Sponsored Genetic Testing Programs Improve Access for Children With Hemophilia A
-
Sep 8, 2026, 10:49Alessandra Bosch: Von Willebrand Disease and Rare Bleeding Disorders, Collaborative Insights and Patient Empowerment
-
Sep 8, 2026, 09:42Vineet Sankhla: Rethinking Potent P2Y12 Inhibition in AF Patients Undergoing PCI
-
Sep 8, 2026, 09:23Mehdi Mirsaeidi: Platelets and Thromboinflammation in COPD
-
Sep 8, 2026, 09:03Michel Cabrera Ortega: LAAC vs OAC – Which Risk Are We Trading?
-
Sep 8, 2026, 08:58Zehraan Ibni Akbar: Reading Blood Through the Peripheral Smear
-
Sep 8, 2026, 08:50Dirk Sibbing: Potent P2Y12 Inhibition in Patients With Atrial Fibrillation and Acute Coronary Syndrome
-
Sep 8, 2026, 08:39ASH-a-Palooza – Exploring What’s Next in Hematology
-
Sep 8, 2026, 08:23Khaled Musallam: A Masterclass on Thalassemia Care in the MENA Region